Quantcast
Home > Quotes > CERS

Cerus Corporation Common Stock (CERS) Quote & Summary Data

CERS 
$4.88
*  
0.12
2.52%
Get CERS Alerts
*Delayed - data as of Jun. 18, 2019 14:10 ET  -  Find a broker to begin trading CERS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CERS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 4.87 / $ 4.88
Today's High / Low
$ 4.935 / $ 4.76
Share Volume
550,652
50 Day Avg. Daily Volume
957,754
Previous Close
$ 4.76
52 Week High / Low
$ 8.05 / $ 4.485
Market Cap
672,639,407
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
550,652
50 Day Avg. Daily Volume:
957,754

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.47

Trading Range

The current last sale of $4.88 is 8.81% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 4.935 $ 8.05
 Low: $ 4.76 $ 4.485

Company Description (as filed with the SEC)

We are a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on our proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Our INTERCEPT Blood System is for use with three blood components: plasma, platelets, and red blood cells. The INTERCEPT Blood System for platelets, or platelet system, and the INTERCEPT Blood System for plasma, or plasma system, have received a broad range of regulatory approvals, including but not limited to U.S.  ... More ...  



Risk Grade

Where does CERS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 4.76
Open Date:
Jun. 18, 2019
Close Price:
$ 4.76
Close Date:
Jun. 17, 2019


Consensus Recommendation

Analyst Info